98 related articles for article (PubMed ID: 4028024)
1. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.
Ohta S; Honda A; Tokutake Y; Yoshida H; Hanai N
Cancer Immunol Immunother; 1993; 36(4):260-6. PubMed ID: 8439988
[TBL] [Abstract][Full Text] [Related]
3. Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides.
Zhang S; Helling F; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1995 Feb; 40(2):88-94. PubMed ID: 7882387
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.
Hersey P; Edwards A; D'Alessandro G; MacDonald M
Cancer Immunol Immunother; 1986; 22(3):221-31. PubMed ID: 3460702
[TBL] [Abstract][Full Text] [Related]
5. Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.
Chapman PB; Gillies SD; Houghton AN; Reilly RM
Cancer Immunol Immunother; 1994 Sep; 39(3):198-204. PubMed ID: 7522964
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones. Markers for gliomas and neuroblastomas.
Bosslet K; Mennel HD; Rodden F; Bauer BL; Wagner F; Altmannsberger A; Sedlacek HH; Wiegandt H
Cancer Immunol Immunother; 1989; 29(3):171-8. PubMed ID: 2471592
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.
Bröcker EB; Zwadlo G; Suter L; Brune M; Sorg C
Cancer Immunol Immunother; 1987; 25(2):81-6. PubMed ID: 3664532
[TBL] [Abstract][Full Text] [Related]
8. Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.
Liao SK; Smith JW; Kwong PC
Cancer Immunol Immunother; 1984; 17(2):95-9. PubMed ID: 6205747
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.
Suter L; Bröcker EB; Brüggen J; Ruiter DJ; Sorg C
Cancer Immunol Immunother; 1983; 16(1):53-8. PubMed ID: 6556951
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.
Feyles V; Dixon WT; Sikora LK; McGarry RC; Jerry LM
Cancer Immunol Immunother; 1991; 32(5):261-72. PubMed ID: 1847843
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric assessment of the reactivity of a panel of monoclonal antibodies (mAb) against two populations of human dendritic cells (DC).
Nunez R; Filgueira L
BMC Immunol; 2001; 2():6. PubMed ID: 11504561
[TBL] [Abstract][Full Text] [Related]
12. Cellular stress- and transformation-associated cell surface antigens expressed on human and rodent tumor cells.
Torigoe T; Tsuboi N; Wada Y; Qi W; Ohtani S; Kishi A; Sato N; Kikuchi K
Jpn J Cancer Res; 1993 Jun; 84(6):673-80. PubMed ID: 8340256
[TBL] [Abstract][Full Text] [Related]
13. SOX-10 and TRP-1 expression in feline ocular and nonocular melanomas.
Orlandi M; Porcellato I; Sforna M; Lo Giudice A; Giglia G; Mechelli L; Brachelente C
Vet Pathol; 2024 Apr; ():3009858241244850. PubMed ID: 38613415
[TBL] [Abstract][Full Text] [Related]
14. Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue.
Matzku S; Brüggen J; Bröcker EB; Sorg C
Cancer Immunol Immunother; 1987; 24(2):151-7. PubMed ID: 3829049
[TBL] [Abstract][Full Text] [Related]
15. Specific oncogene activation of the cell of origin in mucosal melanoma.
Babu S; Chen J; Robitschek E; Baron CS; McConnell A; Wu C; Dedeilia A; Sade-Feldman M; Modhurima R; Manos MP; Chen KY; Cox AM; Ludwig CG; Yang J; Kellis M; Buchbinder EI; Hacohen N; Boland GM; Abraham BJ; Liu D; Zon LI; Insco ML
bioRxiv; 2024 Apr; ():. PubMed ID: 38712250
[TBL] [Abstract][Full Text] [Related]
16. Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen.
Imai K; Nakanishi T; Noguchi T; Yachi A; Ferrone S
Cancer Immunol Immunother; 1983; 15(3):206-9. PubMed ID: 6555062
[TBL] [Abstract][Full Text] [Related]
17. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
18. The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis.
Ahrens TD; Bang-Christensen SR; Jørgensen AM; Løppke C; Spliid CB; Sand NT; Clausen TM; Salanti A; Agerbæk MØ
Front Cell Dev Biol; 2020; 8():749. PubMed ID: 32984308
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
